Literature DB >> 18955504

Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Daizo Koinuma1, Shuichi Tsutsumi, Naoko Kamimura, Hirokazu Taniguchi, Keiji Miyazawa, Makoto Sunamura, Takeshi Imamura, Kohei Miyazono, Hiroyuki Aburatani.   

Abstract

The Smad2 and Smad3 (Smad2/3) proteins are principally involved in the transmission of transforming growth factor beta (TGF-beta) signaling from the plasma membrane to the nucleus. Many transcription factors have been shown to cooperate with the Smad2/3 proteins in regulating the transcription of target genes, enabling appropriate gene expression by cells. Here we identified 1,787 Smad2/3 binding sites in the promoter regions of over 25,500 genes by chromatin immunoprecipitation on microarray in HaCaT keratinocytes. Binding elements for the v-ets erythroblastosis virus E26 oncogene homolog (ETS) and transcription factor AP-2 (TFAP2) were significantly enriched in Smad2/3 binding sites, and knockdown of either ETS1 or TFAP2A resulted in overall alteration of TGF-beta-induced transcription, suggesting general roles for ETS1 and TFAP2A in the transcription induced by TGF-beta-Smad pathways. We identified novel Smad binding sites in the CDKN1A gene where Smad2/3 binding was regulated by ETS1 and TFAP2A. Moreover, we showed that small interfering RNAs for ETS1 and TFAP2A affected TGF-beta-induced cytostasis. We also analyzed Smad2- or Smad3-specific target genes regulated by TGF-beta and found that their specificity did not appear to be solely determined by the amounts of the Smad2/3 proteins bound to the promoters. These findings reveal novel regulatory mechanisms of Smad2/3-induced transcription and provide an essential resource for understanding their roles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955504      PMCID: PMC2612478          DOI: 10.1128/MCB.01038-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.

Authors:  N G Denissova; C Pouponnot; J Long; D He; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Authors:  K Pardali; A Kurisaki; A Morén; P ten Dijke; D Kardassis; A Moustakas
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

3.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2.

Authors:  J Zhang; S Hagopian-Donaldson; G Serbedzija; J Elsemore; D Plehn-Dujowich; A P McMahon; R A Flavell; T Williams
Journal:  Nature       Date:  1996-05-16       Impact factor: 49.962

4.  Regulation of Smad7 promoter by direct association with Smad3 and Smad4.

Authors:  R P Nagarajan; J Zhang; W Li; Y Chen
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.

Authors:  Y Geng; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.

Authors:  Qiaoran Xi; Wei He; Xiang H-F Zhang; Hong-Van Le; Joan Massagué
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

7.  Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.

Authors:  Shogo Ehata; Aki Hanyu; Makoto Hayashi; Hiroyuki Aburatani; Yukio Kato; Makoto Fujime; Masao Saitoh; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

8.  Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

Authors:  M R Keeton; S A Curriden; A J van Zonneveld; D J Loskutoff
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

9.  Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter.

Authors:  M B Datto; Y Yu; X F Wang
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

10.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868

View more
  98 in total

1.  TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.

Authors:  Naoki Oshimori; Daniel Oristian; Elaine Fuchs
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

2.  Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.

Authors:  Alba Gonzalez-Junca; Kyla E Driscoll; Ilenia Pellicciotta; Shisuo Du; Chen Hao Lo; Ritu Roy; Renate Parry; Iliana Tenvooren; Diana M Marquez; Matthew H Spitzer; Mary Helen Barcellos-Hoff
Journal:  Cancer Immunol Res       Date:  2018-12-11       Impact factor: 11.151

3.  Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery.

Authors:  Joanna Boros; Ian J Donaldson; Amanda O'Donnell; Zaneta A Odrowaz; Leo Zeef; Mathieu Lupien; Clifford A Meyer; X Shirley Liu; Myles Brown; Andrew D Sharrocks
Journal:  Genome Res       Date:  2009-08-17       Impact factor: 9.043

4.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

5.  Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase.

Authors:  Peter Lönn; Michael Vanlandewijck; Erna Raja; Marcin Kowanetz; Yukihide Watanabe; Katarzyna Kowanetz; Eleftheria Vasilaki; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

6.  Regulation of transforming growth factor-beta-dependent cyclooxygenase-2 expression in fibroblasts.

Authors:  Takayoshi Matsumura; Toru Suzuki; Kenichi Aizawa; Daigo Sawaki; Yoshiko Munemasa; Junichi Ishida; Ryozo Nagai
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Smad4-dependent pathways control basement membrane deposition and endodermal cell migration at early stages of mouse development.

Authors:  Ita Costello; Christine A Biondi; Jennifer M Taylor; Elizabeth K Bikoff; Elizabeth J Robertson
Journal:  BMC Dev Biol       Date:  2009-10-22       Impact factor: 1.978

8.  Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.

Authors:  Nashi Widodo; Didik Priyandoko; Navjot Shah; Renu Wadhwa; Sunil C Kaul
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

9.  Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.

Authors:  Yingxin Zhao; Bing Tian; Rovshan G Sadygov; Yueqing Zhang; Allan R Brasier
Journal:  J Proteomics       Date:  2016-07-25       Impact factor: 4.044

10.  AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Charis Eng
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.